4) CBIPR-BSL4 RIID

Abstract

Performs T&E and provides the essential data packages to support US Food and Drug Administration approval of leading biodefense medical countermeasure candidates to protect the Warfighter and the Nation

Document Details

Document Type
Accomplishment
Publication Date
Oct 01, 2022
Source ID
d8cad19691559594a8afc78fc95426df

Related Documents